These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 33887423)

  • 1. A cluster of Achromobacter xylosoxidans led to identification of Pseudomonas aeruginosa and Serratia marcescens contamination at a long-term-care facility.
    Dunne EM; Hylsky D; Peterson E; Voermans R; Ward A; Turner K; Hahn C; Arduino M; Ball C; Carter KK; Lee JR
    Am J Infect Control; 2021 Oct; 49(10):1331-1333. PubMed ID: 33887423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of β-lactams in combination with avibactam against multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Achromobacter xylosoxidans isolates from patients with cystic fibrosis.
    Mathy V; Grohs P; Compain F
    J Med Microbiol; 2018 Sep; 67(9):1217-1220. PubMed ID: 30016231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New vector tools with a hygromycin resistance marker for use with opportunistic pathogens.
    Kalivoda EJ; Horzempa J; Stella NA; Sadaf A; Kowalski RP; Nau GJ; Shanks RM
    Mol Biotechnol; 2011 May; 48(1):7-14. PubMed ID: 20972648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic insights into intrinsic and acquired drug resistance mechanisms in Achromobacter xylosoxidans.
    Hu Y; Zhu Y; Ma Y; Liu F; Lu N; Yang X; Luan C; Yi Y; Zhu B
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1152-61. PubMed ID: 25487802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibilities and bacteriological characteristics of bovine Pseudomonas aeruginosa and Serratia marcescens isolates from mastitis.
    Ohnishi M; Sawada T; Hirose K; Sato R; Hayashimoto M; Hata E; Yonezawa C; Kato H
    Vet Microbiol; 2011 Dec; 154(1-2):202-7. PubMed ID: 21783330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of Achromobacter xylosoxidans highly resistant to aminoglycoside antibiotics.
    Nakamoto S; Goda N; Hayabuchi T; Tamaki H; Ishida A; Suzuki A; Nakano K; Yui S; Katsumata Y; Yamagami Y; Burioka N; Chikumi H; Shimizu E
    Jpn J Antibiot; 2016 Apr; 69(2):113-8. PubMed ID: 27544979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of IMP-type metallo-β-lactamases among multidrug-resistant Achromobacter xylosoxidans.
    Yamamoto M; Nagao M; Hotta G; Matsumura Y; Matsushima A; Ito Y; Takakura S; Ichiyama S
    J Antimicrob Chemother; 2012 Sep; 67(9):2110-3. PubMed ID: 22577105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AcGI1, a novel genomic island carrying antibiotic resistance integron In687 in multidrug resistant Achromobacter xylosoxidans in a teaching hospital in Thailand.
    Pongchaikul P; Santanirand P; Antonyuk S; Winstanley C; Darby AC
    FEMS Microbiol Lett; 2020 Jul; 367(14):. PubMed ID: 32592387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative activity of antimicrobials against
    Spierer O; Miller D; O'Brien TP
    Br J Ophthalmol; 2018 May; 102(5):708-712. PubMed ID: 29459431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology of methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and Serratia marcescens in a long-term care facility for patients with severe motor and intellectual disabilities.
    Kirikae T; Tokunaga O; Inoue Y; Fujino T; Saruta K; Yoshikura H; Kuratsuji T; Miyanomae T
    Jpn J Infect Dis; 2004 Oct; 57(5):226-8. PubMed ID: 15507784
    [No Abstract]   [Full Text] [Related]  

  • 11. In-use contamination of a hospital-grade disinfectant.
    Boyce JM; Havill NL
    Am J Infect Control; 2022 Dec; 50(12):1296-1301. PubMed ID: 35307473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center.
    Van Daele S; Verhelst R; Claeys G; Verschraegen G; Franckx H; Van Simaey L; de Ganck C; De Baets F; Vaneechoutte M
    J Clin Microbiol; 2005 Jun; 43(6):2998-3002. PubMed ID: 15956444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Chain 4-Aminoquinolines as Quorum Sensing Inhibitors in Serratia marcescens and Pseudomonas aeruginosa.
    Aleksić I; Šegan S; Andrić F; Zlatović M; Moric I; Opsenica DM; Senerovic L
    ACS Chem Biol; 2017 May; 12(5):1425-1434. PubMed ID: 28350449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of antimicrobials against biofilms of Achromobacter and Pseudomonas.
    Chang JM; McCanna DJ; Subbaraman LN; Jones LW
    Optom Vis Sci; 2015 Apr; 92(4):506-13. PubMed ID: 25785528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequencing of plasmids pAMBL1 and pAMBL2 from Pseudomonas aeruginosa reveals a blaVIM-1 amplification causing high-level carbapenem resistance.
    San Millan A; Toll-Riera M; Escudero JA; Cantón R; Coque TM; MacLean RC
    J Antimicrob Chemother; 2015 Nov; 70(11):3000-3. PubMed ID: 26209313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad-spectrum antimicrobial activity of secondary metabolites produced by Serratia marcescens strains.
    Clements T; Ndlovu T; Khan W
    Microbiol Res; 2019 Dec; 229():126329. PubMed ID: 31518853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial associates of the southern mole cricket (Scapteriscus borellii) are highly pathogenic.
    Aryal SK; Carter-House D; Stajich JE; Dillman AR
    J Invertebr Pathol; 2017 Nov; 150():54-62. PubMed ID: 28916147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KPC-3-Producing Serratia marcescens Outbreak between Acute and Long-Term Care Facilities, Florida, USA.
    Jimenez A; Abbo LM; Martinez O; Shukla B; Sposato K; Iovleva A; Fowler EL; McElheny CL; Doi Y
    Emerg Infect Dis; 2020 Nov; 26(11):2746-2750. PubMed ID: 33079055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic and phylogenetic analysis of multidrug-resistant Achromobacter xylosoxidans ST273 strain MTYH1 co-carrying bla
    Zhu Z; Xu J; He F
    J Glob Antimicrob Resist; 2021 Jun; 25():110-113. PubMed ID: 33766786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus spp.
    Livingston WK; Elliott AM; Cobbs CG
    Antimicrob Agents Chemother; 1981 Jan; 19(1):114-6. PubMed ID: 6787975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.